Of @ randomized patients , the odds of experiencing grade @ ATE were significantly greater in those who received bevacizumab compared with those who received placebo ( odds ratio , @ ; P = @ ) , whereas an opposite trend was noted for grade @ VTE ( odds ratio , @ ; P = @ ) .